CoChat

Comparing cortical signatures of atrophy between late-onset and autosomal dominant Alzheimer disease

Open access
Dincer, Aylin, Gordon, Brian A., Hari-Raj, Amrita, Keefe, Sarah J., Flores, Shaney, McKay, Nicole S., Paulick, Angela M., Shady Lewis, Kristine E., Feldman, Rebecca L., Hornbeck, Russ C., Allegri, Ricardo, Ances, Beau M., Berman, Sarah B., Brickman, Adam M., Brooks, William S., Cash, David M., Chhatwal, Jasmeer P., Farlow, Martin R., la Fougère, Christian, Fox, Nick C., Fulham, Michael J., Jack, Clifford R., Joseph-Mathurin, Nelly, Karch, Celeste M., Lee, Athene, Levin, Johannes, Masters, Colin L., McDade, Eric M., Oh, Hwamee, Perrin, Richard J., Raji, Cyrus, Salloway, Stephen P., Schofield, Peter R., Su, Yi, Villemagne, Victor L., Wang, Qing, Weiner, Michael W., Xiong, Chengjie, Yakushev, Igor, Morris, John C., Bateman, Randall J., L.S. Benzinger, Tammie · 2020 · NeuroImage: Clinical
Cited by 34

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Abstract

Defining a signature of cortical regions of interest preferentially affected by Alzheimer disease (AD) pathology may offer improved sensitivity to early AD compared to hippocampal volume or mesial temporal lobe alone. Since late-onset Alzheimer disease (LOAD) participants tend to have age-related comorbidities, the younger-onset age in autosomal dominant AD (ADAD) may provide a more idealized model of cortical thinning in AD. To test this, the goals of this study were to compare the degree of overlap between the ADAD and LOAD cortical thinning maps and to evaluate the ability of the ADAD cortical signature regions to predict early pathological changes in cognitively normal individuals. We defined and analyzed the LOAD cortical maps of cortical thickness in 588 participants from the Knight Alzheimer Disease Research Center (Knight ADRC) and the ADAD cortical maps in 269 participants from the Dominantly Inherited Alzheimer Network (DIAN) observational study. Both cohorts were divided into three groups: cognitively normal controls (nADRC = 381; nDIAN = 145), preclinical (nADRC = 153; nDIAN = 76), and cognitively impaired (nADRC = 54; nDIAN = 48). Both cohorts underwent clinical assessments, 3T MRI, and amyloid PET imaging with either 11C-Pittsburgh compound B or 18F-florbetapir. To generate cortical signature maps of cortical thickness, we performed a vertex-wise analysis between the cognitively normal controls and impaired groups within each cohort using six increasingly conservative statistical thresholds to determine significance. The optimal cortical map among the six statistical thresholds was determined from a receiver operating characteristic analysis testing the performance of each map in discriminating between the cognitively normal controls and preclinical groups. We then performed within-cohort and cross-cohort (e.g. ADAD maps evaluated in the Knight ADRC cohort) analyses to examine the sensitivity of the optimal cortical signature maps to the amyloid levels using only the cognitively normal individuals (cognitively normal controls and preclinical groups) in comparison to hippocampal volume. We found the optimal cortical signature maps were sensitive to early increases in amyloid for the asymptomatic individuals within their respective cohorts and were significant beyond the inclusion of hippocampus volume, but the cortical signature maps performed poorly when analyzing across cohorts. These results suggest the cortical signature maps are a useful MRI biomarker of early AD-related neurodegeneration in preclinical individuals and the pattern of decline differs between LOAD and ADAD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.nicl.2020.102491

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 34

Metadata

Authors
Dincer, A., Gordon, B. A., Hari-Raj, A., Keefe, S. J., Flores, S., McKay, N. S., Paulick, A. M., Shady Lewis, K. E., Feldman, R. L., Hornbeck, R. C., Allegri, R., Ances, B. M., Berman, S. B., Brickman, A. M., Brooks, W. S., Cash, D. M., Chhatwal, J. P., Farlow, M. R., la Fougère, C., Fox, N. C., Fulham, M. J., Jack, C. R., Joseph-Mathurin, N., Karch, C. M., Lee, A., Levin, J., Masters, C. L., McDade, E. M., Oh, H., Perrin, R. J., Raji, C., Salloway, S. P., Schofield, P. R., Su, Y., Villemagne, V. L., Wang, Q., Weiner, M. W., Xiong, C., Yakushev, I., Morris, J. C., Bateman, R. J., & L.S. Benzinger, T.
Venue
NeuroImage: Clinical
Publisher
Elsevier BV
Published
2020
Volume
28
Pages
102491
ISSN
2213-1582 (ISSN-L)
OpenAlex
W3095171867
Cited by
34
References
30
FWCI
3.19
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.